Clinical trial
Combination Chemotherapy in Treating Patients With Bladder Cancer
NCT00014534 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00014534 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Bladder Cancer |
| Official title | Phase III Study Comparing Sequential Chemotherapy (AG-ITP) To Cisplatin And Gemcitabine As Adjuvant Treatment After Cystectomy For Transitional Cell Carcinoma Of The Bladder |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, cisplatin, doxorubicin hydrochloride, gemcitabine hydrochloride |
| Enrollment | 42 |
| Start date | Mar 1, 2004 |
| Primary completion | Jul 1, 2005 |
| Completion | Apr 1, 2009 |
| First posted | Jun 10, 2003 |
| Last update posted | Jul 14, 2016 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: